Menu

Blog

Archive for the ‘bioengineering’ category: Page 7

May 24, 2024

A year in training: ESA’s new astronauts graduate

Posted by in categories: bioengineering, biotech/medical, robotics/AI

ESA’s newly graduated astronauts reach the end of one year of rigorous basic astronaut training. Discover the journey of Sophie Adenot, Rosemary Coogan, Pablo Álvarez Fernández, Raphaël Liégeois, Marco Sieber, and Australian Space Agency astronaut candidate Katherine Bennell-Pegg. Selected in November 2022, the group began their training in April 2023.

Basic astronaut training provides the candidates with an overall familiarisation and training in various areas, such as spacecraft systems, spacewalks, flight engineering, robotics and life support systems as well as survival and medical training. They received astronaut certification at ESA’s European Astronaut Centre on 22 April 2024.

Continue reading “A year in training: ESA’s new astronauts graduate” »

May 19, 2024

Vitamin D Alters Mouse Gut Bacteria to give Better Cancer Immunity

Posted by in categories: bioengineering, biotech/medical, health

Researchers at the Francis Crick Institute, the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) and Aalborg University in Denmark have found that vitamin D encourages the growth of a type of gut bacteria in mice which improves immunity to cancer.

Reported today in Science, the researchers found that mice given a diet rich in vitamin D had better immune resistance to experimentally transplanted cancers and improved responses to immunotherapy treatment. This effect was also seen when gene editing was used to remove a protein that binds to vitamin D in the blood and keeps it away from tissues.

Surprisingly, the team found that vitamin D acts on epithelial cells in the intestine, which in turn increase the amount of a bacteria called Bacteroides fragilis. This microbe gave mice better immunity to cancer as the transplanted tumours didn’t grow as much, but the researchers are not yet sure how.

May 19, 2024

DNA-empowered synthetic cells as minimalistic life forms

Posted by in categories: bioengineering, biotech/medical, nanotechnology

Structural and dynamic DNA nanosciences offer unique tools for engineering bottom–up synthetic cells. This Review provides a holistic overview for using DNA as a structural material, for designing functional entities, and for information-processing circuits for adaptive and interactive behaviour.

May 18, 2024

Fyodor D. Urnov: Pioneering Gene Editing for Medical Breakthroughs

Posted by in categories: bioengineering, biotech/medical, genetics

A trailblazer in the field of therapeutic genome editing, Fyodor D. Urnov’s research focuses on developing medicines for devastating genetic diseases.

May 17, 2024

Gene Editing Breakthrough: CRISPR Improves Vision in Clinical Trial

Posted by in categories: bioengineering, biotech/medical, genetics

Jason Comander, MD, PhD, performs the procedure to deliver the CRISPR-based medicine as part of the BRILLIANCE trial in September 2020 at Mass Eye and Ear. Credit: Mass Eye and Ear.

All 14 trial participants, including 12 adults (ages 17 to 63) and two children (ages 10 and 14), were born with a form of Leber Congenital Amaurosis (LCA) caused by mutations in the centrosomal protein 290 (CEP290) gene. They underwent a single injection of a CRISPR/Cas9 genome editing medicine, EDIT-101 in one eye via a specialized surgical procedure. This trial, which included the first patient to ever receive a CRISPR-based investigational medicine directly inside the body, focused primarily on safety with a secondary analysis for efficacy.

No serious treatment or procedure-related adverse events were reported, nor were there any dose-limiting toxicities. For efficacy, the researchers looked at four measures: best-corrected visual acuity (BCVA); dark-adapted full-field stimulus testing (FST), visual function navigation (VNC, as measured by a maze participants completed), and vision-related quality of life.

May 16, 2024

New strategy suppresses unwanted deletion events to make genome editing safer and more precise

Posted by in categories: bioengineering, biotech/medical

A simple and robust strategy developed by KAUST scientists could help to improve the safety and accuracy of CRISPR gene editing, a tool that is already approved for clinical use for the treatment of inherited blood disorders.

May 15, 2024

The State of CRISPR and Gene Editing 2024

Posted by in categories: bioengineering, biotech/medical, food

Following the landmark approval of the first CRISPR-based cell therapy in December 2023, the CRISPR community is looking ahead to the next wave of commercial successes, fueled by continued innovation in the development of new gene editing and delivery tools and technologies. Equally exciting advances are occurring in livestock editing, xenotransplantation, and many other specialties.

In The State of CRISPR and Gene Editing virtual summit, GEN proudly gathers a tantalizing line-up of luminaries from academia and industry to discuss the latest research developments, innovations, and advanced technologies that are expanding the CRISPR toolbox, delivering new therapies to patients and safeguarding our food supply.

May 15, 2024

Why a New Inhalable Lung Cancer Treatment Is So Promising

Posted by in categories: bioengineering, biotech/medical, genetics, health

Cells in the human body chat with each other all the time. One major way they communicate is by releasing tiny spheres called exosomes. These carry fats, proteins, and genetic material that help regulate everything from pregnancy and immune responses to heart health and kidney function.

Now, a new Columbia University study in Nature Nanotechnology demonstrated that these “nanobubbles” can deliver potent immunotherapy directly to tough-to-treat lung cancer tumors via inhalation.

“Exosomes work like text messages between cells, sending and receiving information,” said lead researcher Ke Cheng, PhD, professor of biomedical engineering at Columbia. “The significance of this study is that exosomes can bring mRNA-based treatment to lung cancer cells locally, unlike systemic chemotherapy that can have side effects throughout the body. And inhalation is totally noninvasive. You don’t need a nurse to use an IV needle to pierce your skin.”

May 13, 2024

Cancer-fighting nanorobots seek and destroy tumors

Posted by in categories: bioengineering, biotech/medical, nanotechnology, robotics/AI

Editor’s note: This story is being highlighted in ASU Now’s year in review. Read more top stories from 2018 here.

In a major advancement in nanomedicine, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.

“We have developed the first fully autonomous, DNA robotic system for a very precise drug design and targeted cancer therapy,” said Hao Yan, director of the ASU Biodesign Institute’s Center for Molecular Design and Biomimetics and the Milton Glick Professor in the School of Molecular Sciences.

May 11, 2024

Lavazza2018_Article_CognitiveEnhancementThroughGen.pdf

Posted by in categories: bioengineering, biotech/medical

Using gene editing for human enhancement.


Shared with Dropbox.

Page 7 of 214First4567891011Last